SeaStar Medical regains Nasdaq equity compliance; needs funds by end of July

SeaStar Medical Holding Corp

Confirmed compliance with Nasdaq's $2.5M minimum stockholders' equity requirement; listing matter closed.
Nasdaq warned company must raise additional funds or will be below requirement by end of July 2025.
Subject to Mandatory Panel Monitor until July 1, 2026; future non-compliance may trigger delist determination.
CEO Schloff highlights focus on commercializing QUELIMMUNE and NEUTRALIZE-AKI trial for AKI patients.
Company previously received Panel exception through June 22, 2025; compliance now evidenced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.